New clues on tissue damage identified in rheumatoid arthritis and lupus

(NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases) Research supported by the Accelerating Medicines Partnership (AMP) on Rheumatoid Arthritis and Systemic Lupus Erythematosus (RA/SLE) provides new insights into tissue damage for these autoimmune conditions. These discoveries set the stage for uncovering potential drug target candidates that could advance to experimental treatments. Results of the studies were published today (June 18, 2019) in three papers in Nature Immu...